Percutaneous Nerve Evaluation Test Versus Staged Test Trials for Sacral Neuromodulation: Sensitivity, Specificity, and Predictive Values of Each Technique

PURPOSE: InterStim device is an U.S. Food and Drug Administration approved minimal invasive therapy for sacral neuromodulation for lower urinary tract dysfunction. Before InterStim implantation, a trial with the appropriate screening tests is required to determine patient therapy eligibility. There...

Descripción completa

Detalles Bibliográficos
Autores principales: Banakhar, Mai, Hassouna, Magdy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Continence Society 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083824/
https://www.ncbi.nlm.nih.gov/pubmed/27706006
http://dx.doi.org/10.5213/inj.1630498.249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083824/
https://www.ncbi.nlm.nih.gov/pubmed/27706006
http://dx.doi.org/10.5213/inj.1630498.249

Ejemplares similares